PANP25: Chronic Spontaneous Urticaria: What You Need to Know: An Online Activity

PANP25: Chronic Spontaneous Urticaria: What You Need to Know: An Online Activity

This Symposium from the 2025 Fall Clinical Dermatology Conference for PAs and NPs explores the latest clinical data on the management of chronic spontaneous urticaria (CSU) and features practical insights for incorporating evidence-based diagnosis strategies and advanced treatment options into disease management for patients with CSU.

"We do 4x the daily dose of antihistamines and if patients are not tolerating them or they are refractory we are going right to step 3 in the guidelines and moving past these. We are following these patients very closely. We’re not saying start this therapy and come back in 5 months. Start this therapy and tell me in a week or two weeks if it’s working." – Dr. Kirstin Sokol

This activity is supported by educational grants from Genentech, a member of the Roche Group, Novartis Pharmaceuticals Corporation, and Sanofi and Regeneron Pharmaceuticals, Inc.